Globus Medical Inc. logo

Globus Medical (GMED) stock

GMED · Globus Medical Inc. · NYSE

Website
Market cap
$9.09B
EPS (TTM)
$4.05
Shares out
132.5M

What is the latest news on GMED stock?

INSIDERago
Director Tobin James R exercised 41,666 shares at a strike of $56.30 and sold $3,131,547 worth of shares (41,666 units at $75.16) (SEC Form 4)

4 - GLOBUS MEDICAL INC (0001237831) (Issuer)

All GMED news

When does Globus Medical report earnings?

Globus Medical last reported on Nov 5, 2026, the date it announced on Oct 12, 2026. Before that it reported on Aug 6, 2026 and May 7, 2026. On that schedule the next report would come around early February 2027, with the date usually announced about 3 weeks ahead.

GMED earnings history

Who owns the most GMED stock?

BlackRock, Inc. was the largest reported holder of GMED at the end of Q2 2026, with 10,806,724 shares worth $853.8 million. Next came Jupiter Topco LLC ($647.9 million) and Vanguard Capital Management LLC ($403.5 million). In all, 597 institutions reported $9.5 billion of GMED in their 13F filings.

All GMED fund holders

Are insiders buying or selling GMED?

Insiders are selling. In the last 90 days 2 insiders sold $5.8 million of GMED in trades reported on Form 4. The latest: James R Tobin sold $3.1 million, reported on Nov 12, 2026.

GMED insider trades

Financial highlights

Full financials
Revenue, TTM
$3.14B
Revenue growth
+13.4%
Net income, TTM
$557.64M
Net margin
17.8%
Free cash flow, TTM
$766.55M
Cash
$441.27M

For the twelve months ended Sep 30, 2026, from SEC filings. Not investment advice.

Latest news

25 items

Hiring

Nov 19, 2026

Globus Medical Inc. lists 318 open roles on its careers site as of Nov 19, 2026, the most in Operations (79).

Open roles
318

By team

  • Operations
    79
  • Research & Development
    70
  • General Sales
    65
  • Clinical Services
    25
  • Information Technology
    19
  • Product Marketing (Old) (Inactive)
    12

By location

  • Audubon, PA127
  • Pennsylvania - Limerick32
  • Methuen, MA16
  • Ohio8
  • Illinois7
  • Memphis, TN7

Counted daily from Globus Medical Inc.'s careers site.

GMED rankings

News · 26 weeks27+800%
2026-05-24: 12026-05-31: 12026-06-07: 22026-06-14: 02026-06-21: 02026-06-28: 02026-07-05: 12026-07-12: 12026-07-19: 02026-07-26: 22026-08-02: 32026-08-09: 02026-08-16: 22026-08-23: 12026-08-30: 12026-09-06: 02026-09-13: 22026-09-20: 02026-09-27: 02026-10-04: 02026-10-11: 12026-10-18: 02026-10-25: 02026-11-01: 62026-11-08: 32026-11-15: 0
2026-05-242026-11-15
Mix1490d
  • SEC Filings4(29%)
  • Insider3(21%)
  • M&A2(14%)
  • Other2(14%)
  • Earnings2(14%)
  • Analyst1(7%)
Activity · 52 weeks6741 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news

Globus Medical Inc. (GMED) is a Medical/Dental Instruments company listed on NYSE. In the last 30 days Quantisnow tracked 9 wire items for GMED, including 3 SEC filings, 2 insider trades and 1 M&A update. The most recent was published Nov 12, 2026.

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders. Its offers spine products, such as consists of traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies, such as dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products, comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue based products; and COALITION, COALITION MIS, COALITION AGX, MONUMENT, MAGNIFY-S, HEDRON IATM, HEDRON ICTM, INDEPENDENCE, INDEPENDENCE MIS, FORTIFY and XPAND families, SABLETM, RISE, RISE INTRALIF, RISE-L, ELSA, ELSA ATP, RASS, ALTERA, ARIEL, LATIS, CALIBER and CALIBER-L products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

GMED FAQ

11 questions
  • What does Globus Medical Inc. do?
    Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders. Its offers spine products, such as consists of traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies, such as dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral...
  • What is GMED revenue?
    Globus Medical Inc. (GMED) reported $3.14B of revenue for the twelve months ended Sep 30, 2026. That is up 13.4% from the year before. Revenue for fiscal 2025 was $2.94B.
  • Is GMED profitable?
    Yes. Globus Medical Inc. earned $557.64M in net income for the twelve months ended Sep 30, 2026, a net margin of 17.8%.
  • How much cash and debt does GMED have?
    Globus Medical Inc. reported $441.27M in cash and cash equivalents on its most recent balance sheet in SEC filings.
  • Is Globus Medical Inc. (GMED) hiring?
    Globus Medical Inc. lists 318 open roles on its careers site as of Nov 19, 2026, the most in Operations (79). The most openings are in Audubon, PA, Pennsylvania - Limerick and Methuen, MA.
  • Where does GMED stock trade?
    Globus Medical Inc. (GMED) is listed on NYSE.
  • What sector and industry is GMED in?
    Globus Medical Inc. operates in the Health Care sector, Medical/Dental Instruments industry.
  • When did Globus Medical Inc. go public?
    Globus Medical Inc. (GMED) completed its IPO in 2012.
  • What are analysts saying about GMED?
    Across the last 8 analyst actions on Globus Medical Inc., there were 3 upgrades and 1 downgrade. The most recent action was from BMO Capital Markets: Market Perform with a $78.00 price target on 2026-11-06. Recent price targets range from $64.00 to $112.00.
  • What companies are similar to GMED?
    Notable peers in the same industry include ZBH (Zimmer Biomet Holdings Inc.), MDT (Medtronic plc.), OFIX (Orthofix Medical Inc.), SYK (Stryker Corporation), ATEC (Alphatec Holdings Inc.). Compare GMED side-by-side with any of them on Quantisnow.
  • How can I track GMED on Quantisnow?
    Quantisnow aggregates Globus Medical Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow GMED to receive live email and push alerts on every new disclosure.

Is something on this page wrong, or out of date? Request a change